Franklin Biotechnology Discovery A (FBDIX)
109.20
0.98(0.91%) May 21
| Prev Close: | 109.20 |
|---|
| YTD Return*: | 11.01% |
|---|
| Net Assets*: | 545.33M |
|---|
| Yield*: | 0.07% |
|---|
* As of 28-Feb-13
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Morning Read: Biotech Under the Microscopeat Barrons.com(Tue, May 14)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Tue, Apr 9)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Fri, Nov 23)
- Top 5 Zacks #1 Ranked Healthcare Mutual FundsZacks(Mon, Oct 29)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Oct 17)
- Zacks#1 Ranked Healthcare Mutual FundsZacks(Thu, Sep 13)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Sep 5)
- Zacks #1 Ranked Healthcare Mutual FundsZacks(Mon, Aug 13)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Aug 1)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Jun 13)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Mar 21)
- Top 5 Best Performing Healthcare Mutual Funds Year to DateZacks(Wed, Mar 21)
Fund Basics
| Morningstar Overall Rating: | |
| Total Assets: | 545.33M |
| Category: | Health |
|---|
| Annual Report Expense Ratio (net): | 1.26% |
|---|
Performance & Risk
| YTD Return: | 11.01% |
| 5y Avg Return: | 14.10% |
| Rank in Category (ytd): | 5 |
| % Rank in Category (ytd): | 3.57% |
| Beta (3y): | 0.88 |
| Morningstar Risk Rating: | 4 |
Fund Summary
The investment seeks capital appreciation.
Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. It predominantly invests in equity securities, primarily common stock. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of foreign or U.S. issuer. It is non-diversified.
View More